NEW YORK STATE COMMON RETIREMENT FUND - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$17
+21.4%
133,8680.0%0.00%
Q4 2022$14
-99.9%
133,8680.0%0.00%
Q3 2022$20,000
-93.4%
133,868
-61.4%
0.00%
Q2 2022$305,000
-33.0%
346,662
-5.6%
0.00%
Q1 2022$455,000
-36.5%
367,044
-0.0%
0.00%
-100.0%
Q4 2021$716,000
+94.6%
367,052
+173.6%
0.00%
Q3 2021$368,000
-28.7%
134,173
-18.1%
0.00%
-100.0%
Q2 2021$516,000163,9000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 20,000$14,0000.02%
Hartford Financial Management Inc. 16,000$11,0000.00%
RBF Capital, LLC 25,000$19,0000.00%
Koshinski Asset Management, Inc. 20,000$14,0000.00%
Financial Advocates Investment Management 23,097$16,0000.00%
D.A. DAVIDSON & CO. 110,000$76,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 162,714$112,0000.00%
HighTower Advisors, LLC 132,328$91,0000.00%
Virtu Financial LLC 15,854$11,0000.00%
BlackRock Inc. 31,631$22,0000.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders